Keiichiro Kosuge

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Serum amyloid A (SAA)-induced remodeling of CSF-HDL

Takashi Miida, Toshiyuki Yamada, Utako Seino et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2006 · 48 citations

Protein Misfolding, Alzheimer's Disease, Biochemistry +1

Severe Starvation Hypoglycemia and Congestive Heart Failure Induced by Thyroid Crisis, with Accidentally Induced Severe Liver Dysfunction and Disseminated Intravascular Coagulation

Chiaki Kobayashi, Hideo Sasaki, Keiichiro Kosuge et al. · Internal Medicine · 2005 · 30 citations · Full text

Heart Failure, Metabolic Disorder, Pharmacotherapy +23

Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents

Osamu Hanyu, Takashi Miida, Keiichiro Kosuge et al. · Clinica Chimica Acta · 2007 · 25 citations

Insulin Resistance, Metabolic Syndrome, Diabetes Management +9

LCAT-dependent conversion rate is a determinant of plasma preβ1-HDL concentration in healthy Japanese

Takashi Miida, Konen Obayashi, Utako Seino et al. · Clinica Chimica Acta · 2004 · 18 citations

Metabolic Syndrome, Lcat-dependent Conversion Rate, Physiology +4